Connexin43 hemichannel block protects against retinal pigment epithelial cell barrier breakdown C Kuo, CR Green, ID Rupenthal, OO Mugisho Acta diabetologica 57, 13-22, 2020 | 61 | 2020 |
Connexin43 hemichannel block inhibits NLRP3 inflammasome activation in a human retinal explant model of diabetic retinopathy HH Louie, A Shome, CYJ Kuo, ID Rupenthal, CR Green, OO Mugisho Experimental eye research 202, 108384, 2021 | 45 | 2021 |
Correlation between the progression of diabetic retinopathy and inflammasome biomarkers in vitreous and serum–a systematic review CYJ Kuo, R Murphy, ID Rupenthal, OO Mugisho BMC ophthalmology 22 (1), 238, 2022 | 18 | 2022 |
Characterization of NLRP3 inflammasome activation in the onset of diabetic retinopathy CYJ Kuo, JJ Maran, EG Jamieson, ID Rupenthal, R Murphy, OO Mugisho International Journal of Molecular Sciences 23 (22), 14471, 2022 | 17 | 2022 |
Aberrant patterns of key epithelial basement membrane components in keratoconus CA Greene, C Kuo, T Sherwin Cornea 36 (12), 1549-1555, 2017 | 5 | 2017 |
Systemic inflammasome biomarkers as predictors of Diabetic Retinopathy Progression: evidence from a pilot study CYJ Kuo, ID Rupenthal, M Booth, R Murphy, OO Mugisho Future Pharmacology 3 (3), 612-624, 2023 | 3 | 2023 |
Characterization of a novel human organotypic retinal culture technique CYJ Kuo, HH Louie, ID Rupenthal, OO Mugisho Journal of Visualized Experiments (JoVE), e62046, 2021 | 1 | 2021 |
Future Therapeutics: Targeting the NLRP3 Inflammasome Pathway to Manage Diabetic Retinopathy Development and Progression CYJ Kuo, ID Rupenthal, R Murphy, OO Mugisho International Journal of Translational Medicine 4 (3), 402-418, 2024 | | 2024 |
Development and characterization of a novel 3D neovascularization model using human donor choroids CYJ Kuo, A Patel, A de Souza, OO Mugisho Investigative Ophthalmology & Visual Science 65 (7), 4970-4970, 2024 | | 2024 |